glp-1 constipation and diarrhea Your guide to side effects Managing Side Effects of GLP-1

Insights into the impact of microbiota in the treatment of NAFLD/NASH and its potential as a biomarker for prognosis and diagnosis

Imbernon M, Saponaro C, Helms HCC, Duquenne M, Fernandois D, Deligia E, Denis RGP, Chao DHM, Rasika S, Staels B, Pattou F, Pfrieger FW, Brodin B, Luquet S, Bonner C, Prevot V

For companies operating in the telehealth, pharmacy compounding, and digital health sectors, FDA is sending a clear message: Compounding cannot be used as a way to mass-market GLP-1 drugs or to bypass FDA approval requirements

Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation